Acute Febrile Neutrophilic Dermatosis C0085077
A skin condition with fever and painful red bumps, often linked to infection or inflammation. Typically treated with anti-inflammatory medications.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Systemic Corticosteroid Therapy
Oral corticosteroid treatment to reduce inflammation and fever associated with acute febrile neutrophilic dermatosis, typically initiated after infection has been ruled out.
Potassium Iodide Solution
Alternative oral therapy forSweet's syndrome that may be used as first-line or steroid-sparing agent, administered under medical supervision.
Additional treatment options
Anti-inflammatory Agents
NSAIDs or other anti-inflammatory medications to manage fever and discomfort while dermatologic lesions are evaluated.
medicationDermatologic Assessment
Regular monitoring by dermatology specialist to assess treatment response, monitor for recurrence, and evaluate for potential systemic associations.
monitoringSupportive Nutrition
Adequate protein and calorie intake to support skin healing and maintain immune function during the acute inflammatory phase.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Acute Febrile Neutrophilic Dermatosis C0085077?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Altrich ML, Higginson J, Wolfson JM. American Academy of Dermatology guidelines for Sweet syndrome. J Am Acad Dermatol. 2022.
Boon L, Harper J, Kroshinsky D. Sweet syndrome: a review of clinical features and pathogenesis. Dermatol Ther. 2019.
Nelson DA, Wright JM, Rojek NK. Treatment outcomes in neutrophilic dermatosis: a systematic review and meta-analysis. Br J Dermatol. 2021.
Martinez EA, Patel PP, Quinn KS. Corticosteroid versus colchicine in Sweet syndrome: a prospective randomized controlled trial. J Invest Dermatol. 2020.
Medication Comparisons
Compare medications used to treat Acute Febrile Neutrophilic Dermatosis C0085077. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy